51
Frank Horner, Ltd. is a subsidiary, a Canadian subsidiary, of
Carter Wallace, Inc.
On the other hand, whereas in the United States it is approved
for treatment of interstitial cystitis, it is not approved in Canada.
As far as any other condition-we are in the same boat as you-
unapproved.
Now, basically the work that I was referring to at the beginning
in sports injuries came about in the year 1965 when clinical re-
search was going on at a frantic pace. In 1966, I reviewed the
results I obtained with DMSO treatment for these various soft
tissue injuries in 1965 and compared them with similar injuries
treated with conventional forms of therapy in 1964 and 1966, using
the parameter of disability time as my guide to efficacy.
Now, remember these are professional baseball players. It was
1965 when there were not these fancy 5-year contracts you read
about today. These were 1-year contracts, and the next year's con-
tract was dependent upon the present year's work, and the motiva-
tion was to get out there and play to enhance their financial
prospects for the next year.
The results were startling. The disability time was a small frac-
tion in 1965, using DMSO treatment, compared to the conventional
treatment used in 1964 and 1966.
Now, I am quoting a short paragraph in a paper I wrote in 1966
that was presented at the Vienna symposium that year. It is very
short.
The significant superiority of DMSO therapy in the treatment of all these types of
acute soft tissue injuries in athletes was quite obvious. It would not be an exaggera-
tion on the part of the author to state that dimethyl sulfoxide was the most
important therapeutic agent available to him in these types of injuries so frequently
encountered by athletes in competitive sports.
To that I may add it is as pertinent in 1980 as it was in 1966.
Now, as Dr. Reedy pointed out——
Mr. PEPPER. I will have to interrupt you. One of the problems we
have here, during the time that the House is in session, is constant
interruption with rollcalls. If we don't go answer and vote, folks
back home will think we are fishing today, instead of being here on
our jobs.
I wonder if it would be possible for you gentlemen at the table
here now to come back after lunch, and you finish, and then also
the witnesses that are scheduled for this afternoon-the Food and
Drug people and Mr. Bennett and Mr. Baum.
We will recess now until 2:30 p.m.
AFTERNOON SESSION
The CHAIRMAN. The committee will come to order, please.
At the time of the recess, Dr. Paul was giving a statement.
Doctor, we welcome you and you may proceed.
Dr. PAUL. I may be a bit repetitive at the beginning because I
forgot exactly where I was.
I was talking about the opinion I have that DMSO is far superior
to any other form of therapy for soft tissue injuries and using as
my parameter of the disability time.
I think this is as valid as a double blind study in view of the
circumstances used in compiling this data and evaluating it.
